Several pradimicin-family antibiotics have recently been found to possess potent antifungal activity, while their aglycones are inactive against fungi. In the course of the production improvement study of pradimicin L ( Fig. 1) by Actinomadura verrucosospora subsp. neohibisca R103-31), a strain numbered A10102 was found to produce a new pradimicin aglycone designated pradimicin Q which exhibited a potent a-glucosidase inhibitory activity in vitro. In this paper, we wish to describe the fermentation, isolation, physico-chemical properties and structure of pradimicin Q. Comparative a-glucosidase inhibitory activities of pradimicin Q and other pradimicin aglycones are also reported.
Strain A10102 was isolated from MNNG-treated A. verrucosospora subsp. neohibisca R103-3 spores according to a procedure as previously described2) and was fermented at 28°C for 14 days on a rotary shaker operating at 200 rpm in a 500-ml Erlenmeyer flask containing 100ml of production medium consisting of soluble starch (Nichiden Kagaku) 1 %, Chemical shifts are given relative to solvent as internal reference at 2.50ppm. Multiplicity and coupling constants (Hz) are in parentheses. Chemical shifts are given relative to DMSO-d6as internal reference for both 13C (39.5 ppm) and *H (2.50 ppm). Coupling constants (Hz) are given in parentheses. which is the same as that of pradimicin M3). As shown in Table 2 , the *H NMRspectrum of pradimicin Q is similar to that ofpradimicin P except for the two up field protons at C-6 and the lack of protons of the alanine moiety. The methine signals at 34.55 and the methylene signals at 3 2.66 and 3 3.10 that are assignable to C-5 (<5C 66.2) and C-6 (<5 30.7), respectively, from "C^H COSY spectral data are all split into a doublet of doublets each, that is the AMXspin system. In the NOESYspectra, NOE's of the methine proton (<5 4.55) to 4-H (3 6.97) and of 4-H to 3-CH3 protons were observed. The 13C NMRspectrum of pradimicin Q is similar to that of pradimicin P except for the A ring carbon signals and the up field shifts (3 30.7) at C-6 (Table   3 ). These assignments were confirmed by the correlation spectroscopy via long range coupling (COLOC)experiments (Fig. 2) . From these spectral data, the structure of pradimicin Q was deduced to be dealanyl 6-dehydroxypradimicin P. The coupling constant values, 9.8 and 4.3Hz at C-5 (Table 2) , however, indicate vicinal couplings of 5-Hax-6-Hax and 5-Hax-6-Heq, respectively, compared with 5-Heq-6-Heq in pradimicin P. Therefore, the hydroxy group at C-5 of pradimicin Q has the equatorial orientation. The CDdata of pradimicin Q (Table 1) shows the same signs as those of pradimicins A and O, suggesting that pradimicin Q has the 5S configuration. Thus, the structure of pradimicin Q is deduced to be dealanyl-7,lldidemethyl-(5S)-pradimicin O (Fig. 1) .
As 5,6-dihydrobenzo[<z]naphthacenequinone compounds have a common and intense UV absorption maximum around 500nm (Table 1) which overlaps with that of /?-nitrophenol released from substrate />-nitrophenyl a-D-glucopyranoside, the amount of /?-nitrophenol was measured after extraction with BuOHat the alkaline pH. Assay conditions are briefly described as follows: 40 [A of for tests or the buffer for the control, 950//1 of 0.7mM />-nitrophenyl a-Dglucopyranoside (Sigma N1377), and 10^1 of a varied concentration of an assay compound in DMSOwere mixed and incubated at 37°C for 15minutes. To the reaction mixture, 1.0ml of 0.2n NaOH and 1.0ml of BuOHwere added and mixed vigorously. Absorbance of the BuOHlayer at 405 nm was measured spectrophotometrically. a-Glucosidase inhibitory activity was expressed in IC50 (/xg/ml) at which the test compound inhibited 50% of the enzyme activity. IC50 was determined from a standard curve of /?-nitrophenol which was prepared from the assay without test compound (0% inhibition) and the assay without enzyme (100% inhibition).
Pradimicin Q shows the most potent a-glucosidase inhibitory activity among the tested analogs, with IC50 of 3/zg/ml (pradimicin N 62 yizg/ml), while pradimicins A, L and P are inactive at 100/zg/ml (Table 4) . Pradimicins M, N, O, P and Q were also subjected to inhibitory activity assays using /?-glucosidase (Sigma G4511), a-and /?-mannosidases (Seikagaku  Kogyo  100962  and  100963, respectively) and a-(Seikagaku Kogyo 100560) and^-galactosidases (Sigma G1875). None of the compoundsshowany inhibitory activity on any enzyme at 100 /xg/ml except for /?-galactosidase.
The /?-galactosidase activity was inhibited by pradimicin M (39.9%), N (32.4%), O (55.4%), P (36.0%) and Q (44.8%), each at 100/ig/ml. Pradimicin Q exhibited neither in vitro antifungal nor antibacterial activities at 100/ig/ml. The cytotoxicities (IC50) against human colon HCT-1 16 cells and mouse melanoma B16-F10 cells were determined to be 75 and 100 /ig/ml, respectively.
